 |
Funding Opportunites - Research
Further details regarding this announcement can be found at:
https://cdn.pfizer.com/pfizercom/2022-01/GMG_2022-RD-CANADA_QI_CardiacAmyloidCenter.pdf?R.PF6jRMIFbEq8hxEHKk5SWAyAB7afrB
|
|
Sponsor/Award: |
PFIZER CANADA INC - QUALITY IMPROVEMENT GRANTS - 2022 COMPETITION FOR CARDIAC AMYLOID CENTRES IN CANADA |
|
|
Grant Amount: |
$50,000 |
|
Deadline: |
Dean's: Contact your Faculty Research Office for deadline details.
Internal: Mar 30, 2022
Sponsor's: Apr 06, 2022
|
|
|
Subject Areas: |
|
|
Description: |
Pfizer Global Medical Grants (GMG) supports the global healthcare community?s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer?s medical and/or scientific strategies.
Pfizer?s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the practice gaps as outlined in the specific RFP. Individual projects requesting up to $50,000 CAN will be considered.
Grants will be distributed following a fully executed agreement. |
|
|
Application Details: |
Grants will be submitted in an online system. Please go to www.cybergrants.com/pfizer/QI and sign in.INDIRECT COSTS OF 28% MUST BE ADDED TO YOUR BUDGET. |
|
NOTE: All Letters of Intent and Full Applications must be processed through Research Development & Services for institutional approval. Requests for Institutional approvals should be received no less than 3 days prior to the posted Sponsor deadline. A ROLA Proposal (bearing applicant, Chair and Dean electronic approvals) is required for each submission. |
|
Western Contacts: |
|
|
|
Sponsor Contacts: |
AMANDA.J.STEIN@PFIZER.COM
P.O. BOX 800
POINTE-CLAIRE/ DORVAL, Quebec, Canada
514 695-0500
|